Retirement Planning Group (New York)’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$345K Buy
892
+4
+0.5% +$1.48K 0.19% 76
2026
Q1
$260K Buy
888
+6
+0.7% +$1.97K 0.17% 79
2025
Q4
$309K Buy
882
+4
+0.5% +$1.35K 0.21% 66
2025
Q3
$284K Buy
878
+4
+0.5% +$1.24K 0.21% 71
2025
Q2
$340K Buy
874
+4
+0.5% +$1.61K 0.3% 53
2025
Q1
$378K Sell
870
-2,683
-76% -$1.08M 0.38% 48
2024
Q4
$1.31M Buy
+3,553
New +$1.49M 1.44% 22

Other funds holding ELV

Retirement Planning Group (New York)'s ELV Position: Q2 2026 in Review

Retirement Planning Group (New York) increased its Elevance Health (ELV) stake by 0.45% in Q2 2026, buying an estimated $1.48K and bringing the position to 892 shares worth $345K. The position accounts for 0.19% of the portfolio, ranked #76.

Retirement Planning Group (New York) first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.31M in Q4 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Retirement Planning Group (New York) held 892 shares of Elevance Health worth $345K as of Q2 2026.
  • Retirement Planning Group (New York) bought 4 Elevance Health shares in Q2 2026, an estimated $1.48K.
  • Elevance Health made up 0.19% of Retirement Planning Group (New York)'s portfolio in Q2 2026, its #76 holding.
  • Retirement Planning Group (New York) first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • Retirement Planning Group (New York)'s Elevance Health position peaked at $1.31M in Q4 2024.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Retirement Planning Group (New York)'s 13F filing for Q2 2026, filed 7 Aug 2026.